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Background
? Introduced in 2004 in the UK 
? >£1billion per annum 
? 22% GP income
? Largest natural experiment in pay for performance 
(P4P) in the world 
? Precursor schemes, e.g. PRICCE
Domains for quality indicators in QOF 2009
? Clinical
? Secondary prevention of 
coronary heart disease
? Cardiovascular disease: 
primary prevention
? Heart failure
? Stroke & TIA
? Hypertension
? Diabetes mellitus
? COPD
? Epilepsy
? Hypothyroid
? Cancer
? Palliative care
? Mental health
? Asthma
? Dementia
? Depression
? Chronic kidney disease
? Atrial fibrillation
? Obesity
? Learning disabilities
? Smoking
? Organisational
? Records and information
? Information for patients
? Education and training
? Practice management
? Medicines management
? Patient experience
? Length of consultations
? Patient survey (access)
? Additional services
? Cervical screening
? Child health surveillance
? Maternity services
? Contraception
Methods
? Secondary analysis of research including quasi-
systematic review
? Medline, EMBASE, CINAHL, PsycINFO, Health Business 
Elite, Health Management Information Consortium, 
British Nursing Index, Econ Lit to January 2010
? 45 research papers
Results
? Health care gains
? Effects on population health and equity
? Costs and cost effectiveness
? Impact on providers and team climate
? Patients’ experience and views
Health gains
? Real but modest gains in some areas, e.g. asthma, diabetes
? No definite improvement in CHD related to QOF
? Better recording in QOF but not untargeted areas
? No improvement in outcomes, except epilepsy   
N Engl J Med 2009;361:368-78.
Population health and equity
? Inequalities related to deprivation slowly narrowing
? Reductions in age-related differences for CVD/diabetes 
? Variable effects for e.g. gender related differences in CHD
Dixon, Khachatryan & Boyce. The public health impact, In Gillam & Siriwardena (eds) The 
Quality and Outcomes Framework, Radcliffe, Oxford 2010.
Lancet 2008; 
372: 728–36
Cost effectiveness 
? No relationship between pay and health gain
? Cost effectiveness evidence for 12 indicators in the 2006 
revised contract with direct therapeutic effect
? 3 most cost-effective indicators were:
? ACEI/ARB for CKD
? Anticoagulants for AF and
? Beta-blockers for CHD
Team working 
? Changing structures, roles and staff – nurse-led care
? Greater use of information technology
? Restratification: ‘chasers’ and ‘chased’
? Emphasis on biomedical focus
? Commodification of care 
? Narrative of ‘no change’
Checkland & Harrison. Impact of QOF on practice organisation and service delivery. 
In Gillam & Siriwardena (eds) The Quality and Outcomes Framework, Radcliffe, Oxford 2010 
Patient experience
? Little research on patient related/reported impact
? Continuity and relationship affected
? Fragmentation of care
? Little explanation provided to patients 
Wilkie. Does the patient always benefit? In Gillam & Siriwardena (eds) 
The Quality and Outcomes Framework, Radcliffe, Oxford 2010
“A slim, active 69-year-old patient attending for influenza vaccine 
was faced with questions about diet, smoking, exercise and 
alcohol consumption. There was no explanation for why these 
questions were asked; they seemed irrelevant to having
a ‘flu vaccine.’ Blood pressure and weight had to be recorded 
and a cholesterol test organised. A short appointment lasted 
almost 15 minutes without the patient having the opportunity to 
ask a question about any aspect of ‘flu vaccine.”
Discussion and debate
? Improved data recording and analysis
? Modest health benefits for individuals and populations
? Narrowing of inequalities in processes of health care
? Opportunity costs contested
? Unintended consequences: on workforce, professionalism
? Negative effect on care: ‘McDonaldisation’
? Re-defined meaning of quality
Conclusions and ways forward
? Leave indicators unchanged and anticipate higher 
achievement each year
? Add new indicators or conditions 
? Select from a larger set of evidence-based measures
? Remove measures once agreed level achieved
? Rotate measures
? New Coalition government has other plans…

